Congrats again to the winners of our 2014 DiabetesMine Patient Voices Scholarship Contest, announced earlier this summer! Over the next weeks, we’ll be featuring an interview with each of them — all leading up to the 2014 DiabetesMine Innovation Summit set for Nov. 21 at Stanford University. That’s our signature invite-only event bringing together patient voices with industry, regulatory, clinical and D-technology leaders. All in the name of fueling innovation, especially in these times of…Read more »
Today we’re proud to announce the winners of our 2014 Patient Voices Contest – an annual scholarship program in which we seek a group of activated patients to participate in our DiabetesMine Innovation Summit held each fall at Stanford University School of Medicine in Palo Alto, CA.
Our winners help represent the larger patient community, expressing our needs and desires to the Powers That Be: pharma industry and regulatory leaders, health insurance execs, clinicians, entrepreneurs,…
Today marks the start of the year’s biggest diabetes conference on U.S. soil, the American Diabetes Association’s 74th Scientific Sessions here in San Francisco. As always, our team from the ‘Mine will be on hand observing what’s new and exciting (or not, for that matter) and we’ll fill you in, of course!
It’s very convenient to have this year’s conference right here in my own backyard, and it’s great to have Mike joining me from…
Interested in attending the 2014 DiabetesMine Innovation Summit at Stanford University on full scholarship*?
You have one month to apply!
Today we’re proud to announce our 2014 Patient Voices Contest – an annual scholarship program in which we seek 10 activated patients who wish to attend and participate in our DiabetesMine Innovation Summit held each fall at Stanford School of Medicine in Palo Alto, CA.
Our winners act as “delegates” for the patient…
John Sjolund is the CEO and co-founder of Timesulin, a company that makes a clever digital insulin pen cap that keeps track of your dosing. You may have heard about their launch in Canada on Oct. 1 and Finland in mid-November, but we’re still awaiting word on the timeline for a U.S. launch… Meanwhile, as head of this company and also a person living with type 1 diabetes for over a quarter-century, John is uniquely…Read more »